For patients with HIV/AIDS who had a baseline CD4+ T-cell count of >500 cells/mL, after a brief decline, the CD4+ T-cell count was maintained at the same level, with no significant difference between the two treatment groups. The gene discussed is CD4; the disease is AIDS.